LXRX · Lexicon Pharmaceuticals, Inc. · Documents
$1.88
-0.01 (-0.27%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$798.70M
Shares
444.96M
Volume · Sep 30
1.74M
Avg daily vol (3M)
2.96M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-09-14 | 2026-09-30 | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-05-06 | 2026-05-04 | |
| 8-K | 2026-04-30 | — | |
| DEF 14A | 2026-03-16 | — | |
| 8-K | 2026-03-05 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-02-02 | 2026-01-29 | |
| 8-K | 2026-01-29 | — | |
| Investor Event Transcript | 2025-12-31 | — | |
| 8-K | 2025-11-10 | 2025-11-06 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| Investor Event Transcript | 2025-09-30 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-07-28 | 2025-07-23 | |
| 8-K | 2025-07-03 | — | |
| 8-K | 2025-06-03 | 2025-06-02 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-22 | — | |
| 8-K | 2025-03-28 | 2025-03-27 | |
| 10-K | 2025-03-07 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2025-01-07 | 2025-01-03 | |
| 8-K | 2025-01-02 | — | |
| 8-K | 2024-11-22 | — | |
| 8-K | 2024-11-20 | 2024-11-19 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-09-16 | 2024-09-13 | |
| 10-Q | 2024-08-02 | 2024-06-30 | |
| 8-K | 2024-08-01 | — | |
| 8-K | 2024-07-08 | 2024-07-03 | |
| 8-K | 2024-07-01 | 2024-06-28 | |
| 8-K | 2024-05-10 | — | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-04-29 | — | |
| DEF 14A | 2024-03-26 | 2024-03-25 | |
| 10-K | 2024-03-25 | 2023-12-31 | |
| 8-K | 2024-03-12 | — |
Showing 1–50 of 127 filings